Research and innovation | REF: RE241 V1

Microfluidics and Tumor DNA - Contribution of digital PCR

Authors: Philippe NIZARD, Aurélie KROL, Pierre LAURENT-PUIG, Valérie TALY

Publication date: February 10, 2015 | Lire en français

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!

Automatically translated using artificial intelligence technology (Note that only the original version is binding) > find out more.

    A  |  A

    Overview

    ABSTRACT

    Digital PCR (polymerase chain reaction) is a way to cross the technological gap in detection and quantification of rare DNA sequences, such as mutations found in tumors. Detection of these rare sequences is of high importance for improving cancer patient care. Their detection in tumors or in biological fluids such as plasma or urine could allow the adaptation of treatment to the precise molecular characteristics of the tumor, and limit risks of recurrence, thereby increasing patient survival. After a brief introduction of the research described, this article first discusses cancer and its biomarkers, then follows with the emergence of digital PCR, and lastly explores the perspectives and potential evolution of digital PCR.

    Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.

    Read the article

    AUTHORS

    • Philippe NIZARD: Research engineer at UMRS1147, Université Sorbonne Paris Cité, INSERM UMR-S1147, Centre universitaire des Saints-Pères, Paris, France

    • Aurélie KROL: Research engineer at UMRS1147, Université Sorbonne Paris Cité, INSERM UMR-S1147, Centre universitaire des Saints-Pères, Paris, France

    • Pierre LAURENT-PUIG: PU-PH, Director of UMRS1147, Université Sorbonne Paris Cité, INSERM UMR-S1147, center universitaire des Saints-Pères, Paris, France

    • Valérie TALY: CNRS Research Associate (CR1) - Head of the "Translational Research and Microfluidics" group, Sorbonne Paris Cité University, INSERM UMR-S1147, Saints-Pères University Center, Paris, France

     INTRODUCTION

    Key points

    Area: Genetic analysis

    Degree of technology diffusion: Emergence | Growth | Maturity

    Technologies involved: Microfluidics, digital PCR, PCR, quantitative PCR, molecular biology

    Applications: Cancer biomarker research

    Key French players: GDR Micro et Nano Fluidique

    Contact: [email protected] ; [email protected]

    You do not have access to this resource.

    Exclusive to subscribers. 97% yet to be discovered!

    You do not have access to this resource.
    Click here to request your free trial access!

    Already subscribed? Log in!


    The Ultimate Scientific and Technical Reference

    A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
    + More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
    From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

    This article is included in

    Bioprocesses and bioproductions

    This offer includes:

    Knowledge Base

    Updated and enriched with articles validated by our scientific committees

    Services

    A set of exclusive tools to complement the resources

    Practical Path

    Operational and didactic, to guarantee the acquisition of transversal skills

    Doc & Quiz

    Interactive articles with quizzes, for constructive reading

    Subscribe now!

    Ongoing reading
    Microfluidics and tumor DNA